Cardiex Discussion, page-12

Craig Coopers package

• Annual salary of US$300,000.
  
  
• A share package is to be offered, subject to shareholder approval, for 6 million shares for no consideration. Shares will be allotted as follows 2 million shares once 30 day volume weighted average share price (VWAP) exceeds $0.05;o 2 million shares once 30 day VWAP exceeds $0.08; and o 2 million shares once 30 day VWAP exceeds $0.12.
  
  There's 5c in this off the bat. 8c and then 12c given a bit of time. As it is, it's underpriced. A leading Sydney urologist is a top 5 holder and the admedus CEO is about number 20-30. Past management own quite a bit and seem to be still holding as far as I know. Cooper and Cairns(kestrel capital) own quite a bit and the chair is well experienced and on the board of some top Aussie coys. They e made their own market with their cpt code and have a great leasing program for sphygmocor in the US. Me and my mrs have used the device in their offices and she's an ICU nurse. She reckons the data she's read on it shows it's very accurate. You get a 4 page printout of you pulse wave velocity, arteries stiffness and central blood pressure. You can only get that in the past via a catheter. So this is the gold standard. It would be being peer reviewed over 4000 times from memory in journals. It's also used in the top US hospitals but it's been a slow slog, mainly due to making their own market and the past board who were too old to carry on. The algorithm is also used in a portable blood pressure monitoring device with sunshine heart from the UK, although a small earner there after costing about 600k to develop. Margins have always been around 80%+. Prior to going to half yearly reporting they strung together 8 consecutive cashflow positive quarters.
  Happy days will return with more market awareness and retail ownership to drive the sp.